The Bigme Hibreak Pro is the world's most potent E-ink smartphone. It destroys everything else on the market, which isn't saying much. The only other devices are the Bigme Hibreak BW and Hibreak ...

Different printers have different ways to help you monitor the ink level. Below, we have explained the methods for some of the most popular printers: HP Epson Brother Canon. Many printers come ...

Say hello to The Minimal Phone. The Minimal Phone is the “First E-Ink QWERTY Phone,” proclaims the company. This is not just another minimalist phone with an E Ink panel that claims to get ...

Walls in many homes play host to art prints or family photos ... The image is then reproduced on the 13.3-inch E-Ink display a few seconds later. The display leverages Spectra 6 color ePaper ...

But one year — and many delays — later, the world’s first Android phone with both an E Ink display and a physical QWERTY keyboard has begun shipping to backers. In broad strokes, the Minimal ...

Android 14 running on an E Ink screen with cellular connectivity and a QWERTY keyboard? Life is no longer but a dream for the backers of the Minimal Phone, which started shipping out units to its ...

Obesity-focused Aardvark Therapeutics is hoping to raise $100 million in an initial public offering (IPO), according to a US Securities and Exchange Commission (SEC) filing. The Californian biopharma ...

10 x 15 in. (25.4 x 38.1 cm.) Subscribe now to view details for this work, and gain access to over 18 million auction results. Purchase One-Day Pass ...

Aard­vark Ther­a­peu­tics filed for an IPO Thurs­day night, mak­ing it the sixth biotech in line this year for a po­ten­tial list­ing … ...

Obesity drug developer Aardvark Therapeutics (NASDAQ:AARD) has filed for a $100M initial public offering. Aardvark (NASDAQ:AARD) didn't disclose any terms in its SEC filing, but indicated in its ...

The buzz around biotech IPOs is continuing through January, with clinical-stage metabolic company Aardvark Therapeutics revealing plans to go public while Hong Kong-listed Ascentage Pharma joins ...